UNSPSC 51101640: Broxyquinoline

This classification denotes an anti-infective agent with the molecular formula C9H5Br2NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UK4C618C8T, chemically known as 5,7-dibromooxine but generally known as broxyquinoline, which bears US NIH Compound Identifier 2453. European Medicines Agency schedules Broxyquinoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05940MIG.

UNSPSC 51101640 Broxyquinoline is a Commodity code that in practice covers pharmaceutical products and related public health supplies procured by state and local health departments and county governments. The recent opportunities tagged under this code show little direct relevance to broxyquinoline itself; instead, the Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, while Seminole County, Florida released an IFB for Naloxone and Safe Drug Deactivation Systems with annual quantities of 1,900 units of Naloxone and 800 deactivation systems. The code appears to serve as a catch-all UNSPSC classification for pharmaceutical and health-related products rather than a specific chemical or therapeutic family, reflecting how some jurisdictions apply broad commodity codes to group related health supply procurements.

Recent activity under the code concentrates in Florida and Illinois, with issuing bodies spanning state health departments and county health authorities. The Illinois Department of Public Health procurement was a completed award using an Invitation for Bid process with a 12-month initial term and renewal options through year three; Seminole County's procurement through an IFB process with a response deadline of July 26, 2026, required quarterly deliveries and included federal compliance obligations tied to FEMA funding. Neither opportunity specified set-asides or enterprise preference programs, and both included standard E-Verify and drug-free workplace requirements. The code shows limited recent activity overall, and the mismatch between the code name (broxyquinoline, a specific antimicrobial agent) and the actual products being procured (broad-spectrum antibiotics, opioid antagonists, and drug disposal systems) signals that this code may not be the primary or consistent UNSPSC classification for pharmaceutical procurement in these jurisdictions.